Greenleaf Trust Portfolio holdings
Greenleaf Trust is a privately held, trust-only bank that manages wealth and administers trusts for families. Bill Johnston started it in 1998 after national banks had swallowed up many regional and community banks, wanting a locally owned firm with fiduciary expertise that would serve families across generations. Johnston had already launched a sister firm, Greenleaf Asset Management, in 1991, and the two merged in 2002. The bank builds portfolios around what matters most to each client, whether personal, family-focused or charitable, and avoids selling its own proprietary products. It opened a separate bank, Greenleaf Trust Delaware, in 2018.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$26.6M |
| 2 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$4.74M |
| 3 |
Labcorp
LH
|
+$3.42M |
| 4 |
iShares Core S&P Small-Cap ETF
IJR
|
+$1.97M |
| 5 |
TCF
TCF Financial Corporation Common Stock
TCF
|
+$1.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Stryker
SYK
|
+$50M |
| 2 |
NextEra Energy
NEE
|
+$7.15M |
| 3 |
People Inc
PPLI
|
+$5.69M |
| 4 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
+$1.05M |
| 5 |
Jones Lang LaSalle
JLL
|
+$922K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 76.28% |
| 2 | Miscellaneous | 13.53% |
| 3 | Financials | 2.43% |
| 4 | Technology | 2.13% |
| 5 | Consumer Staples | 1.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
Stryker
SYK
$124B
| $3.66B | 74.26% |
23,613,273
-327,938
| -1% | -$50M |
2013 Q2
18 quarters
|
|
|
2
iShares Core S&P 500 ETF
IVV
$847B
| $318M | 6.44% |
1,181,459
+101,550
| +9% | +$26.6M |
2013 Q2
18 quarters
|
|
|
3
iShares Core S&P Mid-Cap ETF
IJH
$121B
| $66M | 1.34% |
1,737,795
+128,280
| +8% | +$4.74M |
2013 Q2
18 quarters
|
|
|
4
iShares Core S&P Small-Cap ETF
IJR
$103B
| $52.4M | 1.06% |
681,829
+26,172
| +4% | +$1.97M |
2013 Q2
18 quarters
|
|
5
Apple
AAPL
$4.98T
| $21.7M | 0.44% |
513,928
+3,144
| +0.6% | +$131K |
2013 Q2
18 quarters
|
|
6
iShares S&P 500 Growth ETF
IVW
$72.1B
| $18M | 0.37% |
472,120
-4,544
| -1% | -$170K |
2013 Q2
18 quarters
|
|
7
Alphabet (Google) Class C
GOOG
$3.49T
| $15.5M | 0.32% |
296,920
-1,580
| -0.5% | -$80.4K |
2013 Q2
18 quarters
|
|
8
iShares S&P 500 Value ETF
IVE
$49.9B
| $15.3M | 0.31% |
133,682
+814
| +0.6% | +$90.2K |
2013 Q2
18 quarters
|
|
9
iShares MSCI EAFE ETF
EFA
$75.6B
| $14.9M | 0.3% |
212,522
+3,662
| +2% | +$255K |
2013 Q2
18 quarters
|
|
10
State Street Energy Select Sector SPDR ETF
XLE
$40.6B
| $14.4M | 0.29% |
397,218
-4,294
| -1% | -$148K |
2015 Q4
8 quarters
|
|
11
PepsiCo
PEP
$193B
| $14M | 0.29% |
117,151
+1,860
| +2% | +$212K |
2013 Q2
18 quarters
|
|
12
Chubb
CB
$139B
| $13.6M | 0.28% |
93,059
-637
| -0.7% | -$95.2K |
2013 Q2
18 quarters
|
|
13
Honeywell
HON
$69.7B
| $13.2M | 0.27% |
95,363
+423
| +0.4% | +$56.7K |
2013 Q2
18 quarters
|
|
14
iShares MSCI Emerging Markets ETF
EEM
$27.5B
| $12.4M | 0.25% |
263,134
-1,349
| -0.5% | -$62.4K |
2015 Q3
9 quarters
|
|
15
Visa
V
$790B
| $12M | 0.24% |
105,504
-322
| -0.3% | -$35.6K |
2013 Q2
18 quarters
|
|
16
Sherwin-Williams
SHW
$83.1B
| $12M | 0.24% |
87,879
+159
| +0.2% | +$20.9K |
2015 Q2
10 quarters
|
|
17
Vanguard FTSE Emerging Markets ETF
VWO
$117B
| $11.2M | 0.23% |
244,725
+18,475
| +8% | +$826K |
2013 Q2
18 quarters
|
|
|
TCF
18
DELISTED
TCF Financial Corporation Common Stock
TCF
| $11M | 0.22% |
205,359
+31,639
| +18% | +$1.7M |
2015 Q2
10 quarters
|
|
19
3M
MMM
$95.5B
| $10.8M | 0.22% |
55,099
-779
| -1% | -$150K |
2013 Q2
18 quarters
|
|
20
iShares MSCI EAFE Value ETF
EFV
$15.1B
| $10.7M | 0.22% |
388,024
-5,102
| -1% | -$140K |
2014 Q2
14 quarters
|
|
21
Citigroup
C
$197B
| $10.5M | 0.21% |
140,534
+6,088
| +5% | +$450K |
2016 Q3
5 quarters
|
|
22
Roper Technologies
ROP
$47.2B
| $10.2M | 0.21% |
39,478
-767
| -2% | -$197K |
2016 Q3
5 quarters
|
|
23
PayPal
PYPL
$49.2B
| $10.2M | 0.21% |
138,410
+536
| +0.4% | +$38.8K |
2015 Q3
9 quarters
|
|
|
CELG
24
DELISTED
Celgene Corp
CELG
| $9.27M | 0.19% |
88,841
-2,052
| -2% | -$232K |
2013 Q2
18 quarters
|
|
25
US Bancorp
USB
$92.6B
| $9.1M | 0.18% |
169,809
+1,655
| +1% | +$89.1K |
2015 Q4
8 quarters
|
|
Similar funds
Greenleaf Trust's Q4 2017 Portfolio in Review
As of Q4 2017, Greenleaf Trust held 726 positions worth $4.93B, up 8.1% from $4.56B the previous quarter. Its ten largest holdings account for 85% of the portfolio.
Greenleaf Trust's Q4 2017 filing shows 28 new, 272 increased, 163 reduced and 43 closed positions. Its largest new stake was PHYSICIANS REALTY TRUST: 66,522 shares worth $1.2M. The largest sale was Stryker, an estimated $50M.
By sector, the portfolio is most concentrated in Healthcare at 76% of assets, down from 77% a quarter earlier, followed by Miscellaneous and Financials.
- Greenleaf Trust's largest Q4 2017 buy was PHYSICIANS REALTY TRUST: 66,522 shares worth $1.2M.
- Greenleaf Trust added most to iShares Core S&P 500 ETF in Q4 2017, an estimated $26.6M increase.
- Greenleaf Trust's biggest Q4 2017 reduction was Stryker, cutting an estimated $50M.
- Greenleaf Trust fully exited AGNC Investment in Q4 2017, selling an estimated $554K.
- Greenleaf Trust's ten largest holdings make up 85% of its $4.93B portfolio in Q4 2017.
- Greenleaf Trust opened 28 new positions and closed 43 in Q4 2017.
- Greenleaf Trust's portfolio value rose 8.1% quarter-over-quarter to $4.93B.
Based on Greenleaf Trust's 13F filing for Q4 2017, filed 8 Feb 2018.